Our mission
FT3 is a global, open, and collaborative
multi-stakeholder program. We bring together diverse stakeholders and activities to build
synergies and accelerate pragmatic efforts to make personalized medicine an accessible reality for all patients who could benefit from it, starting with cancer and testing.
The program uses a co-creation approach, building with patients for patients. We aim to accelerate the benefits of personalized medicine by generating better evidence, identifying, streamlining and scaling best practices to make them sustainable, creating awareness and building the conditions for better access to targeted medicine in oncology and beyond.
WHY is FT3 relevant?
Personalized and Precision Medicine can transform lives, but its potential benefits have not yet been fully realized.
The PM landscape is rapidly changing and fragmented. Efforts to expand it are piecemeal and disconnected.
Best practices are hard to identify, and lack of standardization on national and global levels is a challenge.
Patients are often unaware that better treatments may exist, and are not able to discuss these options with their doctors.
Even where treatments are available, barriers to access may prevent that treatment from being offered to patients.
Healthcare professionals may need support in interpreting data or in making clinical decisions and recommendations based on data
Do you believe you can contribute to making targeted testing and treatments a wide-spread reality in the health care?
An independent, nonprofit global coalition
contributing funding and/or expertise in-kind.
Patients
HCPs
HTA bodies
Regulators
Payers
Diagnostic companies
Pharmaceutical companies
Medical societies
Patient organizations
Founding members
Testimonials
Personalised medicine has the power to be practice-changing.
We are in the transition era. As patient advocates, we have a responsibility to ensure patients can access and understand this ever-evolving information and be fully informed when making decisions on their care and treatment. Knowledge is power.
The time is now for bringing the goal of personalized medicine for every patient into mainstream healthcare.
Personalized medicine is more than just prescribing patients with genetically matched medicines but it represents, and requires, nothing less than a wholescale culture shift, especially in terms of the role of the patients in determining desired outcomes, participating in informed treatment choices, and actively monitoring use and real-world effects.
Personalized medicine should be guided by the basic idea of treating the patient, not the disease.
Personalized medicine should be guided by the basic idea of treating the patient, not the disease.